Lahar Mehta

Chief Medical Officer/Biotechnology Executive with broad neurological clinical development experience

Role: Chief Medical Officer at Nura Bio
Location: Seattle, WA, US
LinkedIn followers: 500 followers

Healthcare & Human ServicesView LinkedIn profile

About Lahar Mehta

Expertise in Neurological Clinical Development

Experience

Chief Medical Officer
Nura Bio
Dec 2024 — Present

Education

University of Rochester
Fellowship, Experimental Therapeutics, Neuroimmunology
2007 — 2009
University of Utah School of Medicine
Neurology, Neurology Residency Program
2003 — 2006
Naval Medical Center San Diego
General Surgery Internship
1999 — 2000
Washington University in St. Louis
BS, Business Administration
1990 — 1994
Meharry Medical College
Doctor of Medicine (M.D.)
1995 — 1999

Skills

American Board of Psychiatry and Neurology
Clinical Development
Neuroscience
Neurology
Biotechnology
Clinical Trials
Clinical Research
Medicine
Medical Research
Drug Development
Healthcare
Life Sciences
Pharmaceutical Industry
Gcp
Immunology
Medical Affairs

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@nurabio.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Nura Bio

Biotechnology · 35 employees · Founded 2018 · South San Francisco, California, United States

At Nura Bio (previously known as Proneurotech Inc.), we envision a world where the diagnosis of a neurological disorder comes with the hope of a cure. Expanding on recent breakthroughs in crucial neurodegenerative pathways, we are positioned to deliver transformative neuroprotective therapies to prevent and protect against neuronal loss and related neuroimmune dysregulation. Our research and development strategy is currently centered on two approaches: prevention of neuronal loss to preserve neurological function; and restoring the function of the neuron-glia axis to improve the nervous system’s immune surveillance capacity in response to neurological injury. Our discovery engine and emerging multi-target pipeline spans these approaches and is well positioned to address a broad range of neurological diseases. Nura Bio’s lead program is the SARM1 inhibitor program. SARM1, has recently emerged an axon-intrinsic metabolic sensor that is a pivotal driver of axonal degeneration and neuronal integrity. Axon degeneration is an early event in several neurological disorders, and halting it early has tremendous potential in the treatment of central, peripheral, and ocular neurological diseases.

nurabio.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Lahar Mehta

Experience

Chief Medical Officer

Education

University of Rochester

University of Utah School of Medicine

Naval Medical Center San Diego

Washington University in St. Louis

Meharry Medical College

Skills

Find verified contacts for anyone on LinkedIn